How is Myelofibrosis Staged: Roudntable - HealthTree for Myelofibrosis
[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Roundtable: How is Myelofibrosis Staged: with Dr. John Mascarenhas, Dr. Raajit Rampal and Dr. Lucia Masarova

Roundtable: How is Myelofibrosis Staged: with Dr. John Mascarenhas, Dr. Raajit Rampal and Dr. Lucia Masarova image

Roundtable: How is Myelofibrosis Staged: with Dr. John Mascarenhas, Dr. Raajit Rampal and Dr. Lucia Masarova

event Apr 04, 2025 / 02:30PM - 03:30PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon
videocam
Can't make it to the event?
We send a recording to all registered participants of the event!

Event Description

Join us for our first HealthTree for Myelofibrosis Roundtable to hear from three of the leading myelofibrosis experts about how myelofibrosis is staged and what those stages mean for you as a patient.

Schedule & Agenda

The panelist Dalton Bean
2:30 PM
Introductions
Dalton Bean

Dalton introduces the agenda of the event and our featured speakers Dr. John Mascarenhas, Dr. Raajit Rampal and Dr. Lucia Masarova

The panelist Lucia Masarova, MD
2:35 PM
What is Myelofibrosis and How Is It Staged?
Lucia Masarova, MD

Dr. Lucia Masarova shares an overview of myelofibrosis and how it's staged 

The panelist Raajit Ramal, MD, PhD
2:55 PM
What is "Low-Risk" Myelofibrosis and Treatment Options
Raajit Ramal, MD, PhD

Dr. Rampal discusses "low-risk" myelofibrosis and what treatment looks like for this group of patients. 

The panelist John Mascarenhas, MD
3:15 PM
What is "High-Risk" Myelfibrosis and Treatment Options
John Mascarenhas, MD

Dr. Mascarenhas discusses high-risk myelofibrosis and treatment options for this group

The panelist Audience
3:35 PM
Questions and Answers
Audience

Type your questions in the chat for our experts to answer! 

Speakers & Moderators

The panelist Dalton Bean
Dalton Bean
Lehi, UT

Dalton joined HealthTree in 2024 as the CLL and MF Education Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.

Read Bio
The panelist Lucia Masarova, MD
Lucia Masarova, MD
Houston, TX

Dr. Lucia Masarova is an Assistant Professor at the Leukemia Department at the MD Anderson Cancer Center. Her clinical and research focus is on myeloproliferative neoplasms, and she is particularly interested in developing novel therapies to address the complex needs of MPN patients.

Read Bio
The panelist John Mascarenhas, MD
John Mascarenhas, MD
New York, NY

John Mascarenhas, MD, is a Professor of Medicine at the Icahn School of Medicine at Mount Sinai. Dr. Mascarenhas is the Director of the Center of Excellence for Blood Cancers and Myeloid Disorders, directs the Adult Leukemia Program, and is a member of The Tisch Cancer Institute. His clinical and research focus centers around myeloproliferative neoplasms (MPNs) and acute myeloid leukemia (AML). Throughout his illustrative career, Dr. Mascarenhas has published over 275 papers, is the principal investigator for the National Cancer Institute sponsored Myeloproliferative Disease Research Consortium, and has served as principal investigator or study chair on numerous clinical trials geared toward innovative treatment approaches for MPNs and AML. Dr. Mascarenhas is widely recognized for his work in MPNs and is often invited to speak at conferences for his expertise in the field.

Read Bio
The panelist Raajit Ramal, MD, PhD
Raajit Ramal, MD, PhD
New York, NY

Raajit Rampal, MD, PhD, is a Hematological Oncologist at the Memorial Sloan Kettering Cancer Canter, New York, KY, specializing in myeloproliferative neoplasms (MPNs) and leukemia. Dr. Rampal is a dedicated and active researcher focusing on developing new and innovative approaches to treating MPNs and leukemia. He also works to develop and run novel clinical trials with molecularly targeted agents for patients with MPNS and leukemia.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Newly Diagnosed group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Follicular lymphoma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.